Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,726 papers from all fields of science
Search
Sign In
Create Free Account
Factor VIII measurement
Known as:
Anti-hemophilic Factor
, FACTVIII
, Factor VIII
The determination of the amount of factor VIII present in a sample.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Antihemophilic Factor, Human Recombinant
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name
Clinical Data Interchange Standards Consortium Terminology
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Pharmacokinetic analysis of anti‐hemophilic factor in the obese patient
A. Graham
,
K. Jaworski
Haemophilia
2014
Corpus ID: 9384369
Standard dosing for individuals with hemophilia A is based on body weight such that 50 IU kg−1 is defined as a 100% dose, or one…
Expand
1992
1992
Postfiltration factor VIII and fibrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C
M. Spivey
,
E. Jeter
,
J. Lazarchick
,
J. Kizer
,
L. Spivey
Transfusion
1992
Corpus ID: 28632703
The 13th edition of the standards of the American Association of Blood Banks specified storage at 1 to 6 degrees C for…
Expand
Highly Cited
1989
Highly Cited
1989
Expression of Human Anti-Hemophilic Factor IX in the Milk of Transgenic Sheep
A. J. Clark
,
Hagop Bessos
,
+8 authors
Ian Wilmut
Bio/Technology
1989
Corpus ID: 11642854
Transgenic livestock may prove useful for the large scale production of valuable proteins. By targeting expression to the mammary…
Expand
Highly Cited
1985
Highly Cited
1985
Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinations
B. Horowitz
,
M. Wiebe
,
A. Lippin
,
M. Stryker
Transfusion
1985
Corpus ID: 22233518
Use of the organic solvent, tri(n‐butyl)phosphate (TNBP), and detergents for the inactivation of viruses in labile blood…
Expand
Highly Cited
1985
Highly Cited
1985
Inactivation of viruses in labile blood derivatives. II. Physical methods
B. Horowitz
,
M. Wiebe
,
A. Lippin
,
J. Vandersande
,
M. Stryker
Transfusion
1985
Corpus ID: 7471950
The thermal inactivation of viruses in labile blood derivatives was evaluated by addition of marker viruses (VSV, Sindbis, Sendai…
Expand
Highly Cited
1983
Highly Cited
1983
Impaired cell-mediated immunity in patients with classic hemophilia.
M. Lederman
,
O. Ratnoff
,
J. Scillian
,
P. Jones
,
B. Schacter
New England Journal of Medicine
1983
Corpus ID: 46265566
THREE cases of Pneumocystis carinii pneumonia, two of which were fatal, have recently been observed in patients with severe…
Expand
1967
1967
Antihemophilic Factor Release by Perfused Liver and Spleen: Relationship to Hemophilia
J. C. Norman
,
J. Lambilliotte
,
Y. Kojima
,
H. Sise
Science
1967
Corpus ID: 25980468
As judged by perfusion of isolated organs an antihemophilic factor is produced in the liver and the spleen. Perfusates (from…
Expand
1957
1957
The pathogenesis of hemophilia; an experimental analysis of the anticephalin hypothesis in hemophilic dogs.
J. Graham
,
E. Barrow
1957
Corpus ID: 73024446
It has been possible to duplicate in the hemophilic dog four of the major experiments which have suggested in humans an…
Expand
1955
1955
Deficiency of anti-hemophilic factor in a woman, combined with a disturbance in vascular function.
S. V. van Creveld
,
F. L. Jordan
,
K. Punt
,
H. A. Veder
Acta Medica Scandinavica
1955
Corpus ID: 31168714
1953
1953
Properties of Bovine Anti-Hemophilic Factor
T. Spaet
,
B. Kinsell
Proceedings of the Society for Experimental…
1953
Corpus ID: 36278606
Summary The anti-hemophilic factor (AHF) of human plasma is unstable to storage, and shows great loss with attempts at…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE